Invention Grant
- Patent Title: Sulfide alkyl compounds for HBV treatment
-
Application No.: US14957020Application Date: 2015-12-02
-
Publication No.: US09597332B2Publication Date: 2017-03-21
- Inventor: Austin Chen , Yalda Bravo , Nicholas Stock , Bijan Pedram , Jason Jacintho , Ryan C. Clark
- Applicant: NOVIRA THERAPEUTICS, INC.
- Applicant Address: US PA Doylestown
- Assignee: NOVIRA THERAPEUTICS, INC.
- Current Assignee: NOVIRA THERAPEUTICS, INC.
- Current Assignee Address: US PA Doylestown
- Agency: Lathrop & Gage LLP
- Agent Brian C. Trinque
- Main IPC: A61K31/5375
- IPC: A61K31/5375 ; A61K31/18 ; A61K31/196 ; A61K31/24 ; A61K31/337 ; A61K31/341 ; A61K31/351 ; A61K31/397 ; A61K31/495 ; A61K31/4453 ; A61K45/06 ; C07C323/62 ; C07D309/08 ; C07D295/155 ; C07D307/16 ; C07D305/06 ; C07D295/192 ; C07D487/10
Abstract:
The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
Public/Granted literature
- US20160151375A1 SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT Public/Granted day:2016-06-02
Information query
